DHA Pharmacist Drug Interactions and Safety — Questions and Answers
Question 1: What is serotonin syndrome and which drug combinations increase its risk?
- A common cold symptom
- A potentially life-threatening condition caused by excess serotonin from combinations like SSRIs with tramadol, MAOIs, or triptans (Correct answer)
- A side effect of antibiotics
- A condition only caused by illegal drugs
Correct answer: A potentially life-threatening condition caused by excess serotonin from combinations like SSRIs with tramadol, MAOIs, or triptans
Serotonin syndrome results from excessive serotonergic activity, commonly triggered by combining SSRIs/SNRIs with MAOIs, tramadol, triptans, or linezolid, presenting with agitation, hyperthermia, and neuromuscular changes.
Question 2: What is the QT prolongation risk that DHA pharmacists must screen for?
- QT prolongation is not clinically significant
- Certain medications (macrolides, fluoroquinolones, antipsychotics, antiemetics) can prolong the QT interval, risking fatal cardiac arrhythmias (Correct answer)
- Only cardiac medications cause QT prolongation
- QT prolongation only occurs in children
Correct answer: Certain medications (macrolides, fluoroquinolones, antipsychotics, antiemetics) can prolong the QT interval, risking fatal cardiac arrhythmias
DHA pharmacists must screen for QT-prolonging drug combinations including macrolides (azithromycin), fluoroquinolones (moxifloxacin), antipsychotics (haloperidol), and antiemetics (ondansetron), especially in patients with risk factors.
Question 3: What are the key drug-food interactions DHA pharmacists must counsel patients about?
- Food never affects medications
- Grapefruit with statins/CCBs, dairy with fluoroquinolones/tetracyclines, vitamin K-rich foods with warfarin, and tyramine-rich foods with MAOIs (Correct answer)
- Only grapefruit interactions matter
- Food interactions are theoretical only
Correct answer: Grapefruit with statins/CCBs, dairy with fluoroquinolones/tetracyclines, vitamin K-rich foods with warfarin, and tyramine-rich foods with MAOIs
Key drug-food interactions include grapefruit inhibiting CYP3A4 (affecting statins, CCBs), dairy chelating antibiotics, vitamin K-rich foods opposing warfarin, and tyramine-containing foods causing hypertensive crisis with MAOIs.
Question 4: What is the clinical significance of CYP450 enzyme interactions for DHA pharmacists?
- CYP450 interactions are not clinically relevant
- CYP450 enzyme inhibition or induction can significantly alter drug levels, causing toxicity or therapeutic failure (Correct answer)
- Only affects metabolism of one drug class
- Only relevant for IV medications
Correct answer: CYP450 enzyme inhibition or induction can significantly alter drug levels, causing toxicity or therapeutic failure
CYP450 enzyme interactions are clinically critical: inhibitors (ketoconazole, erythromycin) increase drug levels risking toxicity, while inducers (rifampicin, carbamazepine) decrease levels causing therapeutic failure.
Question 5: What is the pharmacist's role in preventing adverse drug reactions (ADRs) in Dubai?
- ADRs cannot be prevented
- Screen prescriptions for interactions, assess patient risk factors, adjust doses for renal/hepatic impairment, and monitor for early ADR signs (Correct answer)
- Only report ADRs after they occur
- ADR prevention is only the prescriber's responsibility
Correct answer: Screen prescriptions for interactions, assess patient risk factors, adjust doses for renal/hepatic impairment, and monitor for early ADR signs
DHA pharmacists prevent ADRs through proactive screening of prescriptions for interactions and contraindications, assessing individual risk factors, recommending dose adjustments, and educating patients on warning signs.
Question 6: What are the risks of polypharmacy in elderly patients that DHA pharmacists must address?
- Elderly patients should take as many medications as needed without concern
- Increased risk of drug interactions, adverse effects, falls, cognitive impairment, non-adherence, and medication cascade (Correct answer)
- Polypharmacy only affects young patients
- No special considerations for elderly patients
Correct answer: Increased risk of drug interactions, adverse effects, falls, cognitive impairment, non-adherence, and medication cascade
Polypharmacy in elderly patients increases risks of drug interactions, ADRs, falls (from sedatives, antihypertensives), cognitive decline, poor adherence, and medication cascading (treating side effects with more drugs).
DHA Pharmacist Drug Interactions and Safety
What is serotonin syndrome and which drug combinations increase its risk?